The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation—implications for preventative treatment approaches

Although cytomegalovirus (CMV) infection after allogeneic stem cell transplantation (SCT) is rarely fatal, the management of CMV by pre-emptive medication for viral reactivation has toxicity and carries a financial burden. New strategies to prevent CMV reactivation with vaccines and antiviral T cell...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Cytotherapy (Oxford, England) Ročník 16; číslo 7; s. 927 - 933
Hlavní autoři:	Jain, Natasha A., Lu, Kit, Ito, Sawa, Muranski, Pawel, Hourigan, Christopher S., Haggerty, Janice, Chokshi, Puja D., Ramos, Catalina, Cho, Elena, Cook, Lisa, Childs, Richard, Battiwalla, Minoo, Barrett, A. John
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England Elsevier Inc 01.07.2014
Témata:	Adolescent Adult Advanced Basic Science Aged antiviral cellular therapy Child CMV reactivation Cost of Illness Cytomegalovirus - genetics Cytomegalovirus - pathogenicity Cytomegalovirus Infections - economics Cytomegalovirus Infections - pathology Cytomegalovirus Infections - virology economic cost Female Hematologic Neoplasms - mortality Hematologic Neoplasms - pathology Hematologic Neoplasms - therapy Hematopoietic Stem Cell Transplantation - adverse effects Hematopoietic Stem Cell Transplantation - economics Humans Male Middle Aged Other pre-emptive therapy Risk Factors T-Lymphocytes - immunology T-Lymphocytes - pathology T-Lymphocytes - virology Tissue Donors Transplantation, Homologous - adverse effects Transplantation, Homologous - economics Virus Activation - genetics economic cost CMV reactivation pre-emptive therapy antiviral cellular therapy
ISSN:	1465-3249, 1477-2566, 1477-2566
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!